BICO’s CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model
The breakthrough was achieved by CELLINK’s longtime customer CTIBIOTECH and the NOVOPLASM Research Consortium by leveraging 3D bioprinted skin and cold plasma wound healing treatment Today BICO’s CELLINK, a leader in 3D bioprinting, announced that its BIO X has enabled the production of the world’s first immunized skin model. The breakthrough was achieved by CELLINK’s customer and partner of more than four years, CTIBIOTECH, a French regenerative medicine company. The technology was achieved by converging technologies that include 3D bioprinting, tissue engineering and human cells,